(FDA MedWatch definition) when the patient outcome is: death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent impairment or damage A woman [ age not state
British National Formulary (BNF). Pharmaceutical Press: London, UK, 2015. 37 Gauderman WJMJ. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydrauscedu/gxe, 2006. 38 Valipour G, Saneei P, Esmaillzadeh A. Serum vitamin D ...
lildobnfoabyt se[.tkw(gbe])eiTnnhatehllecbodoreyrlestal.aFctoihorann(abg)eeatiwnnde2e(5nb(O)thnHe =)d D2e6l3tab(1ec0fho–ar1ne4ga eyneidnar12s5)5, (mPOeiHnar)asDfotne3 r'bs telhifnoeereeaxraernrecdgisr1ee shasniaodftne.r Delta of changes in vitamin D ...
(1974) The story of vitamin D: from vitamin to hormone. Lancet i, 325-329.Kodicek E (1974) The story of vitamin D: From vitamin to hormone. Lancet ii:235Kodicek, E. 1974. The story of vitamin D, from vita- min to hormone. Lancet. 1: 325-329....
(teearstle--lbteiumcttoeixvPyeCcaRHrbaDosnAsayCyl)-6f7o-rionxKhoChiab1ei.p1ttoyirnl [37]; (B) R-eM2a-Dlm-tAeimt-hMeyBlPp-4rCo5Rp3aacneselstlashyitorfaaotners)Kf,eaCctase1edl.e1wcitniivthMe cHDoDnAtAr-oMCl6Bsii-Rn4hN5i3Abicteo(slril-s[c3t7rl]a);n(asBnf)edcRtseeiaRdlN-...